Molecular BiologybioRxivPreprint
Empagliflozin reduces neointimal formation and vascular smooth muscle cell proliferation via the suppression of PDGF-related signaling
Wei-Jan Chen, Gwo‐Jyh Chang, Yu‐Juei Hsu, Ying‐Hwa Chen
This study shows empagliflozin reduces neointimal formation and VSMC proliferation by suppressing PDGF-related signaling, independent of SGLT2 and glucose metabolism.
DOI 10.1101/2023.08.14.553316